Navigation Links
Poniard Pharmaceuticals Announces Commercial Supply Agreement for Picoplatin
Date:11/24/2008

SOUTH SAN FRANCISCO, Calif., Nov. 24 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced an agreement with Baxter Oncology GmbH for the commercial manufacture and supply of injectable picoplatin drug product. Poniard is developing picoplatin, its lead product candidate, as a potential new platform product for the treatment of solid tumors. The Company is evaluating picoplatin in four clinical trials, including an ongoing pivotal Phase 3 trial in small cell lung cancer, Phase 2 trials in colorectal and prostate cancers, and a Phase 1 trial of an oral formulation.

"This agreement with Baxter Oncology GmbH for the commercial supply of picoplatin represents the achievement of another important milestone in our plan to develop picoplatin as an oncology platform compound addressing multiple indications, combinations and formulations," said Ronald Martell, president and chief operating officer of Poniard. "Baxter Oncology GmbH's industry-leading technology and state-of-the art finish/fill production capabilities will help ensure we meet our production and quality goals as we move toward commercialization of picoplatin in 2010."

In March 2008, Poniard entered into an agreement with W. C. Heraeus GmbH to manufacture picoplatin active pharmaceutical ingredient (API) and be ready to ship commercial quantities of picoplatin by 2009. Heraeus is the current manufacturer of picoplatin API for the Company's four ongoing clinical trials.

About Picoplatin

Picoplatin has an improved safety profile relative to existing platinum-based cancer therapies and is designed to overcome platinum resistance associated with chemotherapy in solid tumors. It is being studied in multiple cancer indications, combinations and formulations. Pic
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
2. Poniard Pharmaceuticals Announces Upgrade of Stock Listing to NASDAQ Global Market
3. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
5. Poniard Pharmaceuticals Announces Upcoming Conference Participation
6. Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
7. Poniard Pharmaceuticals Appoints Four New Members to Clinical Advisory Board
8. Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31
9. Poniard Pharmaceuticals Announces Upcoming Conference Participation
10. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
11. Poniard Pharmaceuticals Announces Upcoming Conference Participation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... Dec. 11 Marrone Bio Innovations (MBI) ... management team. Mr. Chris Hildreth joined MBI as ... responsible for expanding all commercial aspects of the ... Dr. Kin Sing (Ray) Lam joined MBI as ... company,s development efforts in scaling its broad pipeline ...
(Date:12/10/2009)... Dec. 10 Microban International, Ltd., ... protection, has partnered with Sharp Imaging and ... Sharp Electronics, to incorporate it,s third generation ... calculators. Infused into the calculator keys during ... the growth of damaging bacteria on the ...
(Date:12/10/2009)... - YM BioSciences Inc. (NYSE Amex: YMI ... company that identifies and advances a diverse portfolio ... development, today provided an update on the proposed ... Cytopia Ltd. into YM, details of which were ... directors of Cytopia has unanimously recommended that its ...
(Date:12/10/2009)... DIEGO, Dec. 10 Biomatrica, the leader ... the release of SampleWare 3.1 software system for ... The latest release now includes an audit trail ... provide a more complete history of any stored ... trail feature offers customers a much needed ability ...
Breaking Biology Technology:Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Biomatrica Launches SampleWare 3.1 2Biomatrica Launches SampleWare 3.1 3
... will announce its 2008 third-quarter financial results on Wednesday,Oct. ... will be followed by a live webcast of the ... Eastern), and will be,accessible through Abbott,s Investor Relations Web ... call will be,available after 11 a.m. Central time., ...
... 2008, 5:00 ... EDT, FRAZER, Pa., Sept. 19 Cephalon, Inc.,(Nasdaq: CEPH ) has ... Tuesday,October 28, 2008., ... p.m. EDT Q3 2008 results will be distributed by PRNewswire, 4:50 p.m. ...
... Pa., Sept. 19 Tengion Inc., a clinical,stage ... and neo-tissues, today announced that it was one ... capital-backed innovation and,success at the 35th Anniversary Celebration ... Neff, Partner at Quaker BioVentures -- a,venture capital ...
Other Biology Technology:Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association 2
(Date:12/14/2009)... WAYNE, Pa., Dec. 14 MODA Technology ... monitoring (EM), utility and product testing for the ... MODA 3.0, the company,s third generation mobile data ... (QC) organizations to further automate their regulated manufacturing ... new capabilities: ,, Fully-Configurable Test Methods: ...
(Date:12/13/2009)... resolved a question about how a popular class ... biosensors that reveal previously hidden components of chemical ... and hallucinations characterize the illness, people with schizophrenia ... in a particular order, difficulties that interfere with ... well, said Lee Schroeder, a student in the ...
(Date:12/13/2009)... 2009Researchers at The Scripps Research Institute have solved ... from an ancient family of enzymes can have ... addition to providing guidance for understanding other molecules ... underpinning for the protein,s possible use for combating ... research was published in the December 13, 2009 ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2New biosensors reveal workings of anti-psychotic drugs in the living brain 2Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3St Andrews Country Club Announces Dates and Players for Third Annual Morgan 26amp 3B Friends Fight Cancer Tournament 61156 1St Andrews Country Club Announces Dates and Players for Third Annual Morgan 26amp 3B Friends Fight Cancer Tournament 61156 2MinuteClinic Celebrates National Nurse Practitioner Week and Recognizes Role of Practitioners in Helping To Close Primary Care Gap 61151 1MinuteClinic Celebrates National Nurse Practitioner Week and Recognizes Role of Practitioners in Helping To Close Primary Care Gap 61151 2MinuteClinic Celebrates National Nurse Practitioner Week and Recognizes Role of Practitioners in Helping To Close Primary Care Gap 61151 3Energy saving powder 10692 1Energy saving powder 10692 2Energy saving powder 10692 3
... Va.Coinciding with the observance of Nuclear Medicine Week (October ... (October), SNM released today a new fact sheet highlighting ... improving the ways in which breast cancer is diagnosed ... effective, safe and painless imaging tool for diagnosing and ...
... the hallmarks of spring: a swarm of bees on the move. ... than 5% of the community know the way remains a mystery. ... their new homes, Tom Seeley, a neurobiologist from Cornell University, and ... teamed up to find out how swarms are guided to their ...
... improve the success of oyster restoration efforts in the ... researcher Dr. Elizabeth North is leading a team of ... oysters spawn and where their larvae go in the ... $750,000 competitive grant from the National Science Foundation. , ...
Other Biology News:SNM releases new fact sheet on breast cancer and molecular imaging 2Bee swarms follow high-speed 'streaker' bees to find a new nest 2
...
... L1 Cell Adhesion Molecule ... Xq28, is involved in three distinct conditions: ... Sylvius); 2) MASA (mental retardation, aphasia, shuffling ... paraplegia). Immunogen: Homogenous ...
...
... 2000 One-Step FP Standardization Kit is ... low fluorescence polarization values of fluorescein ... Beacon 2000 System. It also allows ... generated by their instrument to the ...
Biology Products: